Reversing Accumulation of Polyglucosan Bodies by Virally Delivered CRISPR/Cas9 Genome Editing.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 18(2): 866-867 PMID 33847907 DOI 10.1007/s13311-021-01054-1
Abstract
This article has no abstract in PubMed.